Ignite Creation Date:
2024-05-05 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00773240
Status:
COMPLETED
Last Update Posted:
2011-08-30
First Post:
2008-10-15
Brief Title:
A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment
Sponsor:
ALK-Abelló AS
Organization:
ALK-Abelló AS
Organization Data
Organization:
ALK-Abelló AS
Class:
INDUSTRY
Study ID:
GT-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ALK-Abelló AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None